UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

Nature communications, 2017-08, Vol.8 (1), p.268-11, Article 268

2017

Volltextzugriff (PDF)

Clinical feasibility of TBI with helical tomotherapy

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.929-935

2011

Volltextzugriff (PDF)

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant

Bone marrow transplantation (Basingstoke), 2004-04, Vol.33 (8), p.823-828

2004

Volltextzugriff (PDF)

Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model

Bone marrow transplantation (Basingstoke), 2006-10, Vol.38 (7), p.501-506

2006

Volltextzugriff (PDF)

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

Haematologica (Roma), 2012-11, Vol.97 (11), p.1761-1767

2012

Volltextzugriff (PDF)

Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients

Bone marrow transplantation (Basingstoke), 2004-02, Vol.33 (4), p.389-396

2004

Volltextzugriff (PDF)

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Blood cancer journal (New York), 2016-07, Vol.6 (7), p.e453-e453

2016

Volltextzugriff (PDF)

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

Blood, 2000, Vol.95 (1), p.67-71

2000

Volltextzugriff (PDF)

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

Bone marrow transplantation (Basingstoke), 2001-11, Vol.28 (9), p.873-878

2001

Volltextzugriff (PDF)

Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma

The New England journal of medicine, 2006-03, Vol.354 (10), p.1021-1030

2006

Volltextzugriff (PDF)

Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib

Blood cancer journal (New York), 2015-01, Vol.5 (1), p.e272-e272

2015

Volltextzugriff (PDF)

Highly activated and expanded natural killer cells for multiple myeloma immunotherapy

Haematologica (Roma), 2012-09, Vol.97 (9), p.1348-1356

2012

Volltextzugriff (PDF)

P1140: TIME TO TUMOR, SYMPTOMATIC AND LABORATORY RESPONSES FOLLOWING SILTUXIMAB TREATMENT IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE

HemaSphere, 2022-06, Vol.6 (Suppl), p.1030-1031

2022

Volltextzugriff (PDF)

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

Blood cancer journal (New York), 2017-02, Vol.7 (2), p.e535-e535

2017

Volltextzugriff (PDF)

Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2006-02, Vol.37 (4), p.403-409

2006

Volltextzugriff (PDF)

Transplantation as salvage therapy for high-risk patients with myeloma in relapse

Bone marrow transplantation (Basingstoke), 2002-12, Vol.30 (12), p.873-878

2002

Volltextzugriff (PDF)

Human γδ+ T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response

Bone marrow transplantation (Basingstoke), 2001-03, Vol.27 (6), p.601-606

2001

Volltextzugriff (PDF)

Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase : A report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 1997-10, Vol.20 (7), p.553-560

1997

Volltextzugriff (PDF)

High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 1999-10, Vol.24 (8), p.879-883

1999

Volltextzugriff (PDF)

P925: IMPACT OF PRIOR TREATMENT EXPOSURE ON THE EFFECTIVENESS OF IXAZOMIB‐LENALIDOMIDE‐DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED IN ROUTINE CLINICAL PRACTICE (THE INSURE STUDY)

HemaSphere, 2022-06, Vol.6 (Suppl), p.815-816

2022

Volltextzugriff (PDF)

Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation

Bone marrow transplantation (Basingstoke), 2006-03, Vol.37 (5), p.511-515

2006

Volltextzugriff (PDF)

Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation

Cytotherapy (Oxford, England), 2002-01, Vol.4 (1), p.3-10

2002

Volltextzugriff (PDF)

High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine

Bone marrow transplantation (Basingstoke), 1998-11, Vol.22 (9), p.889-893

1998

Volltextzugriff (PDF)

Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma

Haematologica (Roma), 2013-07, Vol.98 (7), p.1147-1153

2013

Volltextzugriff (PDF)

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

Blood, 2000-01, Vol.95 (1), p.67-71

2000

Volltextzugriff (PDF)

1 – 25 von 300

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieLeukemia

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(282)
Mit Volltextzugriff
(271)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(160)
Life Sciences & Biomedicine
(136)
Humans
(131)
Biological And Medical Sciences
(81)
Medical Sciences
(76)
Hematology
(74)
Male
(65)
Female
(63)
Adult
(54)
Middle Aged
(53)
Oncology
(45)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(33)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(33)
Aged
(30)
Immunology
(30)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(29)
Transplantation
(27)
Adolescent
(25)
Bone Marrow
(25)
Stem Cell Transplantation
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bone Marrow Transplantation
(30)
Blood
(28)
Journal Of Clinical Oncology
(28)
British Journal Of Haematology
(15)
Neophilologus
(13)
Amsterdamer Beiträge Zur Älteren Germanistik
(10)
Blood Cancer Journal
(8)
Haematologica
(7)
Cytotherapy
(5)
Experimental Hematology
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

Clinical feasibility of TBI with helical tomotherapy

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant

Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma

Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib

Highly activated and expanded natural killer cells for multiple myeloma immunotherapy

P1140: TIME TO TUMOR, SYMPTOMATIC AND LABORATORY RESPONSES FOLLOWING SILTUXIMAB TREATMENT IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients

Transplantation as salvage therapy for high-risk patients with myeloma in relapse

Human γδ+ T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response

Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase : A report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients

P925: IMPACT OF PRIOR TREATMENT EXPOSURE ON THE EFFECTIVENESS OF IXAZOMIB‐LENALIDOMIDE‐DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED IN ROUTINE CLINICAL PRACTICE (THE INSURE STUDY)

Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation

Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation

High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine

Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

Aktive Filter

Suchergebnisse filtern